HLS Therapeutics Dividends
| HLS Stock | CAD 3.52 0.04 1.12% |
As of the 4th of December 2024, Dividends Paid is likely to grow to about 3.9 M, while Dividend Yield is likely to drop 0.01. HLS Therapeutics' past performance could be the main factor of why investors trade HLS Therapeutics stock today. Investors should clearly understand every aspect of the HLS Therapeutics dividend schedule, including its future sustainability, and how it might impact an overall investment strategy. This tool is helpful to digest HLS Therapeutics' dividend schedule and payout information. HLS Therapeutics dividends can also provide a clue to the current valuation of HLS Therapeutics.
| Last Reported | Projected for Next Year | ||
| Dividends Paid | 2.4 M | 3.9 M | |
| Dividend Yield | 0.02 | 0.01 | |
| Dividend Payout Ratio | (0.09) | (0.09) | |
| Dividend Paid And Capex Coverage Ratio | 6.10 | 5.80 |
HLS |
Investing in stocks that pay dividends is one of many strategies that are good for long-term investments. Ex-dividend dates are significant because investors in HLS Therapeutics must own a stock before its ex-dividend date to receive its next dividend.
HLS Therapeutics Expected Dividend Income Per Share
Dividend payment represents part of HLS Therapeutics' profit that is distributed to its stockholders. It is considered income for that tax year rather than a capital gain. In other words, a dividend is a prize given to shareholders for investing in HLS Therapeutics. HLS Therapeutics' board of directors can pay out dividends at a planned frequency, such as monthly or quarterly.
$0.05 Bottom Scenario | C$0.05 | $0.05 Top Scenario |
One Year
HLS Therapeutics expected dividend income per share adjusted for ongoing price standard deviation